The mechanism of distinct diurnal variations of Renin-Angiotensin system in aorta and heart of spontaneously hypertensive Rats

Clinical and Experimental Hypertension

Volumn 31, Issue 8, 2009, Pages 625-638

  Naito, Yoshiro ^a   Tsujino, Takeshi ^a   Matsumoto, Mika ^a   Okuda, Satoshi ^a   Sakoda, Tsuyoshi ^a   Ohyanagi, Mitsumasa ^a   Masuyama, Tohru ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Circadian rhythm; P22phox; Renin angiotensin system; Spontaneously hypertensive rats; Transforming growth factor 1

Indexed keywords

ALDOSTERONE; ANGIOTENSIN I; ANGIOTENSIN II; CANDESARTAN; MESSENGER RNA; PROTEIN P22; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCADIAN RHYTHM; GENE EXPRESSION; HYPERTENSION; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; BENZIMIDAZOLES; CIRCADIAN RHYTHM; DOWN-REGULATION; GENETIC MARKERS; MALE; MYOCARDIUM; NADPH OXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RENIN-ANGIOTENSIN SYSTEM; SERINE PROTEINASE INHIBITORS; TETRAZOLES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 72749121322     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641960903406993     Document Type: Article

References (38)

1. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989;79:733-743.
2. Angleton P, Chandler WL, Schmer G. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). Circulation 1989;79:101-106.
3. Maemura K, De La Monte SM, Chin MT, Layne MD, Hsieh CM, Yet SF, Perrella MA, Lee ME. CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression. J Biol Chem 2000; 275:36847-36851.
4. Minami Y, Horikawa K, Akiyama M, Shibata S. Restricted feeding induces daily expression of clock genes and Pai-1 mRNA in the heart of Clock mutant mice. FEBS Letters 2002;526: 115-118.
5. Schoenhard JA, Eren M, Johnson CH, Vaughan DE. Alternative splicing yields novel BMAL2 variants: Tissue distribution and functional characterization. Am J Physiol Cell Physiol 2002;283:C103-C114.
6. Van Leeuwen RT, Kol A, Andreotti F, Kluft C, Maseri A, Sperti G. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation 1994;90:362-368.
7. Feener EP, Northrup JM, Aiello LP, King GL. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 1995;95:1353-1362.
8. Vaughan DE, Lazos SA, Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. J Clin Invest 1995;95:995-1001.
9. Morimoto S, Fujioka Y, Hosoai H, Okumura T, Masai M, Sakoda T, Tsujino T, Ohyanagi M, Iwasaki T. The renin-angiotensin system is involved in production of plasminogen activator inhibitor type 1 by cultured endothelial cells in response to chylomicron remnants. Hypertens Res 2003;26:315-323.
10. Naito Y, Tsujino T, Kawasaki D, Naito Y, Tsujino T, Kawasaki D, Okumura T, Morimoto S, Masai M, Sakoda T, Fujioka Y, Ohyanagi M, Iwasaki T. Circadian gene expression of clock genes and plasminogen activator inhibitor-1 in heart and aorta of spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens 2003;21:1107-1115.
11. Okamoto K, Aoki K. Development of a strain of a spontaneously hypertensive rats. Jpn Circ J 1963;27:282-293.
12. Masutani M, Ohyanagi M, Shibuya J, Ishigami Y, Iwasaki T. A decrease in the amount and function of inhibitory GTP-binding protein in the resistance small artery from spontaneously hypertensive rats. Jpn J Pharmacol 1999;79:185-193.
13. Iwahana M, Tokumoto M, Makiishi N, Takatori O, Miyazaki N. Fundamental evaluation of noextraction method of angiotensin I and angiotensin II by radioimmunoassay. J Med Pharm Sci 1996;36:297-303.
14. Naito Y, Tsujino T, Fujioka Y, Ohyanagi M, Iwasaki T. Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats. Hypertension 2002;40:827-833.
15. Nonaka H, Tsujino T, Watari Y, Emoto N, Yokoyama M. Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine: amelioration of homocysteine-induced endoplasmic reticulum stress by taurine. Circulation 2001; 104:1165-1170.
16. Yamanaka K, Takehara N, Murata K, Banno K, Sato T. Pharmacokinetic and pharmacyodynamic study of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor, in spontaneously hypertensive rats. J Pharm Biomed Anal 1997;15:1851-1859. (Pubitemid 27341991)
17. Stouffer GA, Owens GK. Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-b. Circ Res 1992;70:820-828.
18. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK. P22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 1997;80:45-51.
19. Ren Y, Carretero OA, Ito S. Influence of NaCl concentration at the macula densa on angiotensin II-induced constriction of the afferent arteriole. Hypertension 1996;27:649-652.
20. Stepien M, Witte K, Lemmer B. Chronobiologic evaluation of angiotensin-converting enzyme activity in serum and lung tissue from normotensive and spontaneously hypertensive rats. Chronobiol Int 1993;10:331-337.
21. Gordon RD, Wolfe LK, Island DP, Liddle GW. A diurnal rhythm in plasma renin activity in man. J Clin Invest 1996;45:1587-1592.
22. Portaluppi F, Bagni B, Degli Uberti E, Montanari L, Cavallini R, Trasforini G, Margutti A, Ferlini M, Zanella M, Parti M. Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects. J Hypertens 1990;8:85-95.
23. Kala R, Fyhrquist F, Eisalo A. Diurnal variation of plasma angiotensin II in man. Scand J Clin Lab Invest 1973;31:363-365.
24. Yamazaki T, Komuro I, Yazaki Y. Role of the renin-angiotensin system in cardiac hypertrophy. Am J Cardiol 1999;83 (suppl 12A):53H-57H.
25. Wollert KC, Drexler H. The renin-angiotensin system and experimental heart failure. Cardiovasc Res 1999;43:838-849.
26. Taal MW, Brenner BM. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int 2000;57:1803-1817.
27. Morgan T. Renin, angiotensin, sodium and organ damage. Hypertens Res 2003;26:349-354.
28. Kohara K, Brosnihan KB, Ferrario CM. Angiotensin(1-7) in the spontaneously hypertensive rat. Peptides 1993;14:883-891.
29. Sowers J, Tuck M, Asp ND, Sollars E. Plasma aldosterone and corticosterone responses to adrenocorticotropin, angiotensin, potassium, and stress in spontaneously hypertensive rats. Endocrinology 1981;108:1216-1221.
30. Tamura K, Umemura S, Nyui N, Yamakawa T, Yamaguchi S, Ishigami T, Tanaka S, Tanimoto K, Takagi N, Sekihara H, Murakami K, Ishii M. Tissue-specific regulation of angiotensinogen gene expression in spontaneously hypertensive rats. Hypertension 1996;27:1216-1223. (Pubitemid 26165622)
31. Aihara H, Ogawa H, Kasuya A, Yoshida M, Suzuki-Kusaba M, Hisa H, Satoh S. Intrarenal angiotensin converting enzyme inhibition in spontaneously hypertensive rats. Eur J Pharmacol 1999;373:35-40.
32. Mizuno K, Niimura S, Tani M, Haga H, Gomibuchi T, Sanada H, Fukuchi S. Antihypertensive and hormonal activity of MK 954 in spontaneously hypertensive rats. Eur J Pharmacol 1992;215:305-308.
33. Sugano M, Tsuchida K, Sawada S, Makino N. Reduction of plasma angiotensin II to normal levels by antisense oligodeoxynucleotides against liver angiotensinogen cannot completely attenuate vascular remodeling in spontaneously hypertensive rats. J Hypertens 2000;18:725-731.
34. Makino N, Sugano M, Ohtsuka S, Sawada S, Hata T. Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats. Cardiovasc Res 1999; 44:543-548.
35. Sim MK, Qui XS. Angiotensins in plasma of hypertensive rats and human. Regul Pept 2003; 111:179-182.
36. Nakata K, Nishimura K, Takada T, Ikuse T, Yamauchi H, Iso T. Effects of an angiotensinconverting enzyme (ACE) inhibitor, SA446, on tissue ACE activity in normotensive, spontaneously hypertensive, and renal hypertensive rats. J Cardiovasc Pharmacol 1987;9:305-310.
37. Rodriguez-Sargent C, Cangiano JL, Martinez-Maldonado M. Circadian rhythms of plasma renin levels in the anesthetized rat. Ren Physiol 1982;5:53-56.
38. Ferrario CM, Trask AJ, Jessup JA. Advances in biochemical and functional roles of angiotensinconverting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 2005;289:H2281-290.